New AHA scientific statement on menopause and CVD riskDecember 2, 2020Preventive CareCardiologyWomen's HealthEndocrinologyMixed Topics
Don’t miss cardiovascular risk factors in transgender patientsNovember 13, 2020DiabetesPreventive CareCardiologyEndocrinology
Denosumab favored over alendronate for BMD protection in glucocorticoid-induced osteoporosisNovember 9, 2020RheumatologyEndocrinologyWomen's Health
Treatment sequence with romosozumab influences osteoporosis outcomesNovember 9, 2020RheumatologyEndocrinologyWomen's Health
First-of-its kind guideline on lipid monitoring in endocrine diseasesNovember 6, 2020DiabetesMen's HealthEndocrinology
Menstrual irregularity appears to be predictor of early deathOctober 27, 2020Women's HealthEndocrinology
Genitourinary syndrome of menopause statement stresses treatment optionsOctober 22, 2020Women's HealthEndocrinology
Fetal estrogens show promise for safer therapy for menopauseOctober 22, 2020Women's HealthEndocrinology
Entresto halves renal events in preserved EF heart failure patientsOctober 15, 2020DiabetesCardiologyEndocrinology
T2D treatments create tension between glycemic and cardiovascular goalsOctober 12, 2020DiabetesPreventive CareCardiologyEndocrinology
